QurCan Therapeutics (formerly known as Nanology Labs) is a biotech company developing next-generation nanoparticles for gene/chemotherapy.
QurCan Therapeutics Inc. has raised $3.0M in total funding. The most recent round was Corporate Round. The last funding was announced in September 2026.
QurCan Therapeutics Inc.'s investors include Eli Lilly, Creative Destruction Lab, Ontario Centre of Innovation, MEDTEQ+, Ramen Ventures.
QurCan Therapeutics Inc. is headquartered in Toronto, Canada.
QurCan Therapeutics (formerly known as Nanology Labs) is a biotech company developing next-generation nanoparticles for gene/chemotherapy.
QurCan Therapeutics Inc. is at the Corporate Round stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"QurCan Therapeutics Inc. — Funding & Investors." VCBacked, September 15, 2026, https://www.vcbacked.co/company/qurcan-therapeutics-inc. Accessed November 12, 2026.
VCBacked. (2026). QurCan Therapeutics Inc. — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/qurcan-therapeutics-inc
{{cite web |title=QurCan Therapeutics Inc. — Funding & Investors |url=https://www.vcbacked.co/company/qurcan-therapeutics-inc |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at QurCan Therapeutics Inc.? Request a listing update